CRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance.

Antibiotics (Basel) · 2023 · PMC10295005 · PMID 37370394

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

Due to the limitation of the CRISPR-Cas system to the domains of archaea and bacteria, the separation, optimization, and production of the CRISPR-Cas transfer carriers and vectors is quite significant for the implementation of RNA-guided nucleases which carry the ability to target new strains for instance, multi-drug resistant (MDR) pathogens and other crucial elements of the endogenous microbiota [ 57 ].

also in 5,705 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.